Literature DB >> 20554208

(E)-2-styrylchromones as potential anti-norovirus agents.

Joana Rocha-Pereira1, Ricardo Cunha, Diana C G A Pinto, Artur M S Silva, Maria São José Nascimento.   

Abstract

Human noroviruses (NoV) are now recognized as the most frequent cause of outbreaks and sporadic cases of acute gastroenteritis. Despite the significant economic impact and considerable morbidity of norovirus disease, no drug or vaccine is currently available to treat or prevent this disease, therefore the discovery of anti-norovirus drugs is urgent. In the present work, a total of 12 structure related chromone and (E)-2-styrylchromones were evaluated for their potential anti-norovirus activity using the murine norovirus (MNV) as a surrogate model for human NoV. From the 12 compounds studied, six (E)-2-styrylchromones were found to have with interesting anti-norovirus activity. The best compounds of the series were (E)-5-hydroxy-2-styrylchromone and (E)-4'-methoxy-2-styrylchromone with an IC(50) approximately 7muM. A first insight into the mechanism of action of these compounds was possible. An interesting relationship between the anti-norovirus activity and the chemical structure was observed. The present study points out that the (E)-2-styrylchromones skeleton is an important one which deserves to be developed and further explored as new antiviral drugs against NoV. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554208     DOI: 10.1016/j.bmc.2010.05.006

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.

Authors:  Auda A Eltahla; Kun Lee Lim; John-Sebastian Eden; Andrew G Kelly; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

Review 2.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

Review 3.  Styrylchromones: Biological Activities and Structure-Activity Relationship.

Authors:  Mariana Lucas; Marisa Freitas; Artur M S Silva; Eduarda Fernandes; Daniela Ribeiro
Journal:  Oxid Med Cell Longev       Date:  2021-12-22       Impact factor: 6.543

Review 4.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

Review 5.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

6.  Antiviral activity of nucleoside analogues against norovirus.

Authors:  Verónica P Costantini; Tony Whitaker; Leslie Barclay; David Lee; Tamara R McBrayer; Raymond F Schinazi; Jan Vinjé
Journal:  Antivir Ther       Date:  2012-08-14

Review 7.  Anti-norovirus therapeutics: a patent review (2010-2015).

Authors:  Anushka C Galasiti Kankanamalage; Pathum M Weerawarna; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Expert Opin Ther Pat       Date:  2016       Impact factor: 6.674

8.  In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase.

Authors:  Salvatore Ferla; Natalie E Netzler; Sebastiano Ferla; Sofia Veronese; Daniel Enosi Tuipulotu; Salvatore Guccione; Andrea Brancale; Peter A White; Marcella Bassetto
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

9.  Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Identification of active compounds.

Authors:  Jana Van Dycke; Jasper Rymenants; Johan Neyts; Joana Rocha-Pereira
Journal:  Antivir Chem Chemother       Date:  2021 Jan-Dec

Review 10.  Progress towards the prevention and treatment of norovirus infections.

Authors:  Armando Arias; Edward Emmott; Surender Vashist; Ian Goodfellow
Journal:  Future Microbiol       Date:  2013-11       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.